# Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia

> **NCT07662330** · NA · RECRUITING · sponsor: **Shanghai 10th People's Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Obesity & Overweight
- Hyperlipidemia

## Interventions

- **DRUG:** Spermidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07662330
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07662330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07662330, "Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07662330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*